|

FX-909 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Flare Therapeutics Inc.1

Indications

  • Open Label1
  • Oral Drug Administration1
  • Advanced Urothelial Carcinoma1
  • Cancer1

San Francisco, California1 trial

A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma

UCSF Helen Diller Family Comprehensive Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.